167 related articles for article (PubMed ID: 26321405)
1. Acne - a potential skin marker of internal disease.
Pace JL
Clin Dermatol; 2015; 33(5):572-8. PubMed ID: 26321405
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
Housman E; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome and acne.
Chuan SS; Chang RJ
Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
[TBL] [Abstract][Full Text] [Related]
5. Dermatologic manifestations of polycystic ovary syndrome.
Lee AT; Zane LT
Am J Clin Dermatol; 2007; 8(4):201-19. PubMed ID: 17645376
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.
Hong JS; Kwon HH; Park SY; Jung JY; Yoon JY; Min S; Choi YM; Suh DH
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):42-7. PubMed ID: 24628922
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
Lowenstein EJ
Dermatol Ther; 2006; 19(4):210-23. PubMed ID: 17004997
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome: a dermatologic approach.
Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M
An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531
[TBL] [Abstract][Full Text] [Related]
9. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
[TBL] [Abstract][Full Text] [Related]
11. Dermatologic manifestation of hyperandrogenism: a retrospective chart review.
Clark CM; Rudolph J; Gerber DA; Glick S; Shalita AR; Lowenstein EJ
Skinmed; 2014; 12(2):84-8. PubMed ID: 24933845
[TBL] [Abstract][Full Text] [Related]
12. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
13. Acne-associated syndromes: models for better understanding of acne pathogenesis.
Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
15. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.
Lujan ME; Chizen DR; Pierson RA
J Obstet Gynaecol Can; 2008 Aug; 30(8):671-679. PubMed ID: 18786289
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome.
Azziz R; Carmina E; Chen Z; Dunaif A; Laven JS; Legro RS; Lizneva D; Natterson-Horowtiz B; Teede HJ; Yildiz BO
Nat Rev Dis Primers; 2016 Aug; 2():16057. PubMed ID: 27510637
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents.
Schroeder B
Curr Womens Health Rep; 2001 Oct; 1(2):124-30. PubMed ID: 12112959
[TBL] [Abstract][Full Text] [Related]
19. Dermatology of androgen-related disorders.
Essah PA; Wickham EP; Nunley JR; Nestler JE
Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
[TBL] [Abstract][Full Text] [Related]
20. Hirsutism and acne in polycystic ovary syndrome.
Archer JS; Chang RJ
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):737-54. PubMed ID: 15380144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]